Pharmaceutical News

RSS

Rosuvastatin vastly superior to six common heart health supplements

Six widely used dietary supplements often advertised to promote heart health are actually ineffective at lowering cholesterol levels.

7 Nov 2022

Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities

In a recent study posted to the medRxiv* preprint server, researchers in Canada evaluated nirmatrelvir and ritonavir (Paxlovid) effectiveness against severe coronavirus disease 2019 (COVID-19) during the dominance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) and Omicron sub-VOCs in Canada.

7 Nov 2022

Paxlovid antiviral therapy reduces risk of long COVID

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].

7 Nov 2022

Two heart failure therapies prove to be nearly identical in reducing death

In a head-to-head comparison of two so-called 'water pills' that keep fluid from building up in patients with heart failure, the therapies proved nearly identical in reducing deaths, according to a large study led by Duke Health researchers.

6 Nov 2022

Weekly weight loss drug reduces BMI in teens

Researchers report that a weekly dose of semaglutide led to a significant BMI reduction in adolescents.

3 Nov 2022

UQ spin-off company to develop precision painkillers for treating debilitating conditions

Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company - potentially changing the lives of millions of people.

3 Nov 2022

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariants

Researchers at Emory University, Stanford University, and the National Institute of Allergy and Infectious Diseases evaluated whether bivalent coronavirus disease 2019 (COVID-19) boosters conferred protection against new Omicron subvariants.

2 Nov 2022

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

A new study led by Ochsner infectious diseases clinical pharmacist Kevin Lin, PharmD, was recently published in PLoS One, suggesting that oral cephalosporins are as safe and effective as the standard of care fluoroquinolones (FQs) for the treatment of acute kidney infections.

2 Nov 2022

The maternal RSV vaccine from Pfizer protects newborns against severe illness

Pfizer announced its maternal vaccine against RSV to be almost 82% effective in protecting infants for the first 90 days of life against severe illness.

1 Nov 2022

UH PREMIER Center receives funding to fight the rising tide of opioid addiction and death

Fighting the rising tide of opioid addiction and death, the Prescription Drug Misuse Education and Research (PREMIER) Center at the University of Houston College of Pharmacy has been funded for the next two years by the Texas Health and Human Services Commission for an additional $3.34 million.

31 Oct 2022

An innovative nasal vaccine strategy to combat COVID

In a recent study published in the journal Science, researchers at Yale University developed a novel coronavirus disease 2019 (COVID-19) vaccination strategy termed 'prime and spike' (P&S) that leveraged existing systemic immunity triggered by parenteral vaccination (prime) to boost immunity at the respiratory mucosa.

31 Oct 2022

Indonesian government orders temporary ban of cough syrups after Gambian tragedy

Following a WHO warning about possible toxic ingredients in four cough syrups of Indian origin, the Indonesian government has ordered a temporary ban on all liquid medicines in the country over reported spike in children's deaths linked to medical syrups.

28 Oct 2022

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariants

A team of researchers from the United States computationally modified the COV2-2130 monoclonal antibody to restore its neutralizing ability against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants, while retaining efficacy against the Delta and wild-type strains.

27 Oct 2022

Updapted BA.4/5 COVID vaccines boost protection but might not surpass original formula

In a recent study posted to the bioRxiv* preprint server, researchers at Beth Israel Deaconess Medical Center assessed the immunogenicity associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BA.5 bivalent messenger ribonucleic acid (mRNA) vaccine boosters.

27 Oct 2022

$38,398 for a single shot of a very old cancer drug

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical.

26 Oct 2022

Study highlights the need to strengthen trust in healthcare to limit antibiotic use

Do many Swedes obtain antibiotics without a prescription, and what drives their behaviour when this happens? The answers are important when it comes to dealing with antibiotic resistance, which is a serious challenge for the entire healthcare sector.

24 Oct 2022

New study highlights how pain management practices are changing after surgery

Although there has been no decrease in the number of opioid prescriptions seniors receive after surgery, the doses of those prescriptions are lower, according to a study of more than a quarter million Canadian patients being presented at the ANESTHESIOLOGY 2022 annual meeting.

24 Oct 2022

Regular statin use may reduce the risk of death and severity of COVID-19

Previous
1
...
74
75
76
77
78
79
80
...
1443
Next

Pharmaceutical News

Rosuvastatin vastly superior to six common heart health supplements

Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbidities

Paxlovid antiviral therapy reduces risk of long COVID

Two heart failure therapies prove to be nearly identical in reducing death

Weekly weight loss drug reduces BMI in teens

UQ spin-off company to develop precision painkillers for treating debilitating conditions

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariants

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

The maternal RSV vaccine from Pfizer protects newborns against severe illness

UH PREMIER Center receives funding to fight the rising tide of opioid addiction and death

An innovative nasal vaccine strategy to combat COVID

Indonesian government orders temporary ban of cough syrups after Gambian tragedy

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariants

Updapted BA.4/5 COVID vaccines boost protection but might not surpass original formula

$38,398 for a single shot of a very old cancer drug

Study highlights the need to strengthen trust in healthcare to limit antibiotic use

New study highlights how pain management practices are changing after surgery

Regular statin use may reduce the risk of death and severity of COVID-19

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News